FGFR4 and breast cancer: According to previous studies, the FGF19/FGFR4 axis played a pivotal role in many different cancers such as hepatocellular carcinoma [36], breast cancer [37], ovarian cancer [38], and prostate cancer [39], which led to their low 5-year survival rates.